The highly expressed GNG2 may also be associated with the down-regulation of miR-23b-3p (0.223-fold change, p < 0.001), which was identified to be associated with various cancers, such as cervical cancer, renal cancer and pancreatic cancer [41,42,43,44]. This evidence concerns the gene GNG2 and pancreatic neoplasm.